Mavyret 100 mg/1

Mavyret 100 mg/1 is a combination of glecaprevir and pibrentasvir, used for treating chronic hepatitis C virus (HCV) infection. This oral medication is designed to target the virus and support liver health.

Mavyret 100 mg/1 is primarily used for the treatment of chronic hepatitis C virus (HCV) infection. It is often prescribed for adults with or without compensated cirrhosis. The medication works by targeting the virus to help manage the infection and improve liver function. Patients may wonder, 'what is Mavyret used for?' and the answer is that it is specifically formulated to address HCV.

Common effects of Mavyret 100 mg/1 may include fatigue, headache, nausea, and diarrhea. Some individuals might experience changes in taste or difficulty sleeping. These effects can vary from person to person, and it's important to consult a healthcare provider for personalized advice.

Mavyret 100 mg/1 should be handled with care, especially for those with liver disease or other medical conditions. It is important to follow the prescribed dosage and administration instructions. Patients should avoid alcohol and certain medications that may interact with Mavyret. Always consult a healthcare provider before starting any new medication.

Mavyret 100 mg/1 may interact with other medications, including those metabolized by the liver. It is important to inform your healthcare provider about all medications you are taking, including over-the-counter drugs and supplements. Alcohol and certain herbal products may also interact with Mavyret, so it's best to avoid them unless advised otherwise.